Telmisartan+Amlodipine Fixed Dose Combination in Hypertension
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objectives of this trial is to evaluate the changes from baseline (Visit 2) in
the 24-hour Ambulatory Blood Pressure Monitoring mean (relative to dose time) for diastolic
blood pressure and systolic blood pressure after 8 weeks of treatment with Telmisartan
80mg/Amlodipine 5mg in patients with moderate to severe hypertension